|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,100 KRW | -1.47% |
|
-0.82% | -15.33% |
| 03-14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
JW Pharmaceutical Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 4,777.36 million compared to KRW 4,827 million a year ago. Net loss was KRW 967.85 million compared to KRW 15,241.28 million a year ago.
Basic loss per share from continuing operations was KRW 40.7767 compared to KRW 636.8932 a year ago. Basic loss per share was KRW 40.7767 compared to KRW 636.8932 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.33% | 520M | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
JW PHARMACEUTICAL CORPORATION 
